Study identifier:BY9010/M1-142
ClinicalTrials.gov identifier:NCT00163423
EudraCT identifier:N/A
CTIS identifier:N/A
Comparison of Ciclesonide (80 mcg Once Daily in the Evening) and Fluticasone propionate (100 mcg Twice Daily) in Patients with Mild to Moderate Asthma
asthma
Phase 3
No
Ciclesonide
All
480
Interventional
12 Years - 75 Years
Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Double Blind
Primary Purpose: Treatment
Verified 01 Dec 2016 by AstraZeneca
AstraZeneca
-
No locations available
Arms | Assigned Interventions |
---|